Perrigo | Pasivo Circulante



Current Liabilities Cambio Fecha
AbbVie USD 36.4B 2.35B 2025-03
Abbott USD 13.44B 435M 2025-06
Bayer EUR 29.78B 1.82B 2025-06
Bristol-Myers Squibb USD 27.53B 3.46B 2025-06
Corcept Therapeutics USD 144.66M 1.6M 2025-06
Dr.Reddys Laboratories INR 142.59B 12.25B 2025-06
Eli Lilly USD 39.02B 8.95B 2025-06
J&J USD 56.9B 6.58B 2025-03
Merck USD 26.04B 863M 2025-06
Nestle CHF 46.82B 3.96B 2025-06
Pacira USD 313.16M 1.57M 2025-06
Perrigo USD 1.13B 52.3M 2025-06
Pfizer USD 37.73B 1.27B 2025-06
Prestige Brands USD 109.67M 3.04M 2025-06
Reckitt Benckiser GBP 7.94B 901M 2024-12
Sanofi 29.06B 3.16B 2025-06
Supernus Pharmaceuticals USD 286.36M 4.59M 2025-06
Teva Pharmaceutical Industries USD 11.86B 704M 2025-06
Xeris Pharmaceuticals USD 95.17M 5.27M 2025-06
Zoetis USD 3.37B 19M 2025-06


Perrigo Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Sep 2025.